Iq Eq Fund Management (Ireland) LTD Amgen Inc Transaction History

Iq Eq Fund Management (Ireland) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $369,519 - $422,880	-1,858 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $41,275 - $48,099	186 Added 11.12%	1,858 $462,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $70,764 - $90,956	-374 Reduced 18.28%	1,672 $403,000
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $356,229 - $426,836	2,046 New	2,046 $396,000

3,054

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.